Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.41M | -2.75M | -3.37M | -2.81M | -2.32M |
| Total Depreciation and Amortization | 34.00K | -26.00K | 8.00K | -44.00K | 12.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.21M | 256.00K | 1.42M | 256.00K | 247.00K |
| Change in Net Operating Assets | -399.00K | -1.97M | -1.30M | -816.00K | -3.42M |
| Cash from Operations | -2.56M | -4.49M | -3.24M | -3.41M | -5.48M |
| Capital Expenditure | 0.00 | -64.00K | -8.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -64.00K | -8.00K | -- | -- |
| Total Debt Issued | 0.00 | 20.00M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 2.00K | 244.00K | 2.45M | 0.00 |
| Repurchase of Common Stock | 0.00 | -262.00K | -484.00K | -141.00K | -2.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 19.74M | -240.00K | 2.31M | -2.57M |
| Foreign Exchange rate Adjustments | -267.00K | -58.00K | 1.28M | 194.00K | -1.86M |
| Miscellaneous Cash Flow Adjustments | -- | -- | 1.00K | -- | -- |
| Net Change in Cash | -2.83M | 15.13M | -2.21M | -906.00K | -9.90M |